This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What Makes Skyward (SKWD) a New Strong Buy Stock
by Zacks Equity Research
Skyward (SKWD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Skyward (SKWD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Skyward (SKWD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Skyward Specialty Insurance (SKWD) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Skyward (SKWD) delivered earnings and revenue surprises of 13.64% and 5.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Heritage Insurance (HRTG) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Heritage Insurance's (HRTG) first-quarter results are likely to benefit from disciplined underwriting, diversification business, rate adequacy and a solid reinsurance program.
ROOT to Come Up With Q1 Earnings: Here's What to Expect
by Zacks Equity Research
The first-quarter performance of ROOT, an auto insurer with a focus on the personal line, is likely to have benefited from better pricing and underwriting technology as well as prudent cost management.
Can AIG Navigate Through Lower Premiums in Q1 Earnings?
by Zacks Equity Research
AIG's first-quarter results are likely to reflect a decline in premiums and growth in net investment income.
CNA Financial (CNA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CNA Financial (CNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Everest Re (EG) Be in Your Kitty Before Q1 Earnings?
by Zacks Equity Research
Everest Re's (EG) first-quarter results are likely to benefit from diversified growth across most lines of business, an increase in property lines, higher new money yields and prudent underwriting.
Is a Beat in Store for Unum Group (UNM) This Earnings Season?
by Zacks Equity Research
Unum Group's (UNM) first-quarter results are likely to benefit from strong persistency in the in-force business, better pricing and solid sales in most of the business segments.
Should Arch Capital (ACGL) Be in Your Kitty Before Q1 Earnings?
by Zacks Equity Research
Arch Capital's (ACGL) first-quarter results are likely to benefit from improved premiums, aided by better pricing and new business opportunities.
Skyward Specialty Insurance (SKWD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Skyward (SKWD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Cincinnati Financial (CINF) Beat Estimates in Q1 Earnings?
by Zacks Equity Research
Cincinnati Financial's (CINF) first-quarter results are likely to reflect the impact of growth initiatives, increased exposure, better pricing and increased property casualty agency, offset by cat loss.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Buy These 4 Low-Beta Stocks to Counter Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Trip.com (TCOM), ADMA Biologics (ADMA), Lantheus (LNTH) and Skyward (SKWD) are well-poised to gain.
Will Skyward (SKWD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Skyward (SKWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are You Looking for a Top Momentum Pick? Why Skyward Specialty Insurance (SKWD) is a Great Choice
by Zacks Equity Research
Does Skyward Specialty Insurance (SKWD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Lincoln National (LNC) Unveils PEPs to Ease Retirement Planning
by Zacks Equity Research
Lincoln National (LNC) launches FlexPEP(k) and FlexPEP(b) to offload the plan sponsorship burden from small-to-medium businesses and not-for-profits, and offer enhanced retirement outcomes to their employees.
Key Highlights From CNO Financial's (CNO) Optavise Report
by Zacks Equity Research
CNO Financial's (CNO) Annual Benefits Broker Survey highlights the growing requirements of broker partners to address employers' regulatory and compliance management concerns.
Skyward Specialty Insurance Group, Inc. (SKWD) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Compelling Reasons to Hold on to Allstate (ALL) Stock Now
by Zacks Equity Research
Allstate (ALL) remains well-poised for growth on the back of continued rate hikes, strong investment results, divestitures and adequate cash reserves.
Best Momentum Stocks to Buy for March 14th
by Zacks Equity Research
SKWD, NVR and IMXI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 14, 2024.
New Strong Buy Stocks for March 14th
by Zacks Equity Research
IMMR, NVR, SKWD, DVA and APAM have been added to the Zacks Rank #1 (Strong Buy) List on March 14, 2024.
Best Value Stocks to Buy for March 14th
by Zacks Equity Research
IMXI, SKWD and DVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 14, 2024.